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Abstract
Background: Much of the Plasmodium falciparum genome encodes hypothetical proteins with
limited homology to other organisms. A lack of robust tools for genetic manipulation of the parasite
limits functional analysis of these hypothetical proteins and other aspects of the Plasmodium
genome. Transposon mutagenesis has been used widely to identify gene functions in many
organisms and would be extremely valuable for functional analysis of the Plasmodium genome.
Results: In this study, we investigated the lepidopteran transposon, piggyBac, as a molecular
genetic tool for functional characterization of the Plasmodium falciparum genome. Through multiple
transfections, we generated 177 unique P. falciparum mutant clones with mostly single piggyBac
insertions in their genomes. Analysis of piggyBac insertion sites revealed random insertions into the
P. falciparum genome, in regards to gene expression in parasite life cycle stages and functional
categories. We further explored the possibility of forward genetic studies in P. falciparum with a
phenotypic screen for attenuated growth, which identified several parasite genes and pathways
critical for intra-erythrocytic development.
Conclusion: Our results clearly demonstrate that piggyBac is a novel, indispensable tool for
forward functional genomics in P. falciparum that will help better understand parasite biology and
accelerate drug and vaccine development.
Background
Malaria is a leading infectious disease that affects 400–
600 million people, causing 2–3 million deaths, every
year [1]. Out of the four Plasmodium species that cause
malaria, Plasmodium falciparum is responsible for much of
the mortality associated with the disease primarily due to
lethal infections in young children of sub-Saharan Africa.
A continuous rise in parasite drug-resistance has further
hindered malaria control strategies and resulted in
increased number of deaths in the last few years [2].
The current post-genome era has witnessed a progression
of functional genomics studies accomplished in P. falci-
parum, providing valuable information about parasite
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biology [3-8]. Despite these enormous efforts, Plasmodium
genomes continue to be perplexing with more than 50%
of the genes coding for hypothetical proteins with limited
homology to model organisms. High throughput meth-
ods for identification of gene functions are imperative to
better understand parasite biology and develop effective
disease control strategies. However, generating gene dis-
ruptions through classic reverse genetic approaches is a
complex and inefficient process in P. falciparum, due to an
extremely low parasite transfection efficiency and the par-
asite's ability to maintain transfected plasmids as epi-
somes, resulting in only less than 1% of the total
annotated genes knocked out thus far [9,10].
Insertional mutagenesis approaches are widely used in
prokaryotes and eukaryotes for genome characterizations.
Specifically, transposon-mediated mutagenesis has
emerged as a powerful molecular genetic tool for eukary-
otic transgenesis [11-14] and is extensively used to create
gene disruptions, trap promoters and enhancers, and gen-
erate gene fusions in model organisms such as Drosophila
and yeast [12,14]. However, the lack of such advanced
genetic approaches in Plasmodium is a major impediment
to elucidating the parasite genome.
piggyBac is a 'cut-and-paste' transposon that inserts into
TTAA target sequences in the presence of a piggyBac trans-
posase [15,16]. piggyBac has gained recent acclamation as
a genetic tool due to its functionality in various organisms
[17-19] and ability to integrate more randomly into
genomes [20]. Moreover, piggyBac's insertion preference
for transcription units [17,20] enhances its efficacy in
large-scale mutagenesis studies to identify gene functions.
We had earlier reported the development of an efficient,
piggyBac-based system for genetic manipulation of P. falci-
parum [21]. In this study, we improved efficiency of the
piggyBac transposition system for P. falciparum and evalu-
ated its application in whole-genome functional analysis
of this most lethal human malaria parasite.
Results
Plasmid design, generation of mutant P. falciparum clones 
and insertion site analyses
piggyBac  insertions into the P. falciparum genome were
obtained by co-transfection of parasite erythrocytic stages
with a transposon plasmid and a transposase-expressing
helper plasmid as described previously [21]. To optimize
the piggyBac system for maximum efficiency, several trans-
poson and transposase plasmids were tested in P. falci-
Plasmid design for piggyBac mutagenesis of P. falciparum Figure 1
Plasmid design for piggyBac mutagenesis of P. falciparum. A summary of different transposon and transposase plasmids 
tested in P. falciparum. Maximum transformation efficiency was obtained while using a dual promoter for transposase expres-
sion.BMC Microbiology 2009, 9:83 http://www.biomedcentral.com/1471-2180/9/83
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parum (Fig. 1). The transposon plasmids tested contained
different regulatory elements and drug selectable markers,
which, however, resulted in similar transformation effi-
ciencies (interpreted as the number of piggyBac insertions
obtained per transfection). As piggyBac transposase is the
functional enzyme catalyzing the integration event, we
hypothesized that increased expression of the transposase
with a stronger promoter would result in increased trans-
formation efficiency. The hsp86 promoter in the helper
plasmid, pHTH [21], was therefore replaced with a previ-
ously described dual Plasmodium promoter, containing 5'
calmodulin and 5' dhfr-ts regions in head to head orienta-
tion [22]. Corroborating our theory, significantly higher
transformation efficiencies (an average of 3.1 × 10-6) were
obtained using the dual promoter for transposase expres-
sion as compared to using pHTH (an average of 1.6 × 10-
6) in approximately 40 transfections each (χ2 test, df 1, P
= 0.015).
Following transfection with piggyBac plasmids, drug resist-
ant parasite populations were established rapidly, within
2–3 weeks and the total number of piggyBac insertions
obtained per transfected parasite population varied from
1 to 14. Through 81 independent transfections, we gener-
ated 177 unique mutant clones of P. falciparum with piggy-
Bac  insertions in their genomes. Southern blot
hybridization analysis of parasite clones, derived by limit-
ing dilution of drug-resistant populations, revealed single
piggyBac insertions in all except two clones that had two
insertions each (data not shown). Also, none of the
mutant clones retained the piggyBac plasmid as episomes
indicating highly efficient transposition events (data not
shown). Out of the 179 piggyBac insertions identified, 165
could be mapped unambiguously on the P. falciparum
genome by performing BLAST searches using NCBI http/
www.ncbi.nlm.nih.gov/genome/seq/BlastGen/Blast
Gen.cgi?taxid=5833 and PlasmoDB [23] databases. The
remaining 14 insertions either mapped to telomeric repet-
itive elements or could not be mapped to a chromosomal
location through BLAST searches of public databases. The
identified  piggyBac  insertion sites were distributed
throughout the genome in all 14 P. falciparum chromo-
somes (Fig. 2a) with no bias for any particular chromo-
some (Fig. 2b). All piggyBac insertions were obtained in
the expected TTAA target sequences except two that inte-
grated into TTAT and TTAG sequences. As in other organ-
isms [17,20], piggyBac  preferentially inserted into
predicted transcribed units of P. falciparum genome (Fig.
3a), affecting 178 transcription units. Thirty-six of the
insertions resulted in direct disruption of open reading
frames (ORFs) and 3 insertions were mapped to introns.
A vast majority of insertions (119) occurred in 5' untrans-
lated regions (UTRs) whereas only a few (22) were
obtained in 3' UTRs (Additional file 1).
piggyBac inserts randomly into all categories of genes with 
a strong preference for 5' untranslated regions
Obtaining unbiased insertions into the genome is critical
for whole-genome mutagenesis and other large-scale anal-
yses. Hence, we evaluated the randomness of piggyBac
insertions into the P. falciparum genome by comparing the
functional categories of genes with piggyBac insertions to
all annotated genes in the genome. An identical func-
tional distribution of genes was seen in both piggyBac
insertion loci and the genome (Fig. 3b) except for fewer
insertions in genes involved in DNA metabolism/DNA-
binding and invasion/pathogenesis (Fisher's exact test, P
= 0.038 and P = 0.04, respectively). Since the parasite
erythrocytic stages were used for piggyBac transformation,
we further investigated the bias for piggyBac insertions in
erythrocytic stage genes relative to genes expressed in
other stages of development. By utilizing the gene expres-
sion profiling data for P. falciparum [3], we classified all
annotated genes based on their expression in different
parasite life cycle stages and confirmed unbiased piggyBac
insertions in genes expressed in all parasite stages (Fig.
3c). A separate comparison of genes with piggyBac inser-
tions in coding sequences only to all genes also revealed
no significant insertion bias for any functional category or
stage of expression (data not shown).
Even though transposon-mediated mutagenesis is a rela-
tively random process, preferential insertion into genomic
hotspots is characteristic of some transposons [20]. In our
studies, we observed a significantly higher number of pig-
gyBac  insertions in 5' UTRs and a significantly lower
number in coding sequences, relative to a distribution of
214 randomly selected genomic TTAA sequences (Fig.
3d).
A putative motif for piggyBac insertion in the P. 
falciparum genome
Previous studies in other organisms had observed some
AT-richness around piggyBac  insertion sites [17,24].
However, it was somewhat surprising that our analysis of
a 100 bp flanking region showed a significantly higher
AT-content around piggyBac  inserted TTAA sequences
(average AT content of 85.56%) as compared to random
TTAA sequences (average AT content of 80.24%), in the
already AT-rich P. falciparum genome (two-tailed t-test, P
= 2.95 × 10-13). A closer look at the piggyBac insertion
sites revealed their presence in the middle of an AT-rich
core of 10 nucleotides predominantly with 'T's upstream
and 'A's downstream (Fig. 4a, upper panel). No such sig-
nature motif was present around the randomly selected
TTAA sequences either from the genome (Fig. 4a, lower
panel). Even when only analyzing the genomic 5' UTRs,
a similar bias in the insertion site selection existed (Fig.
4b).BMC Microbiology 2009, 9:83 http://www.biomedcentral.com/1471-2180/9/83
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Distribution of piggyBac insertion sites in the P. falciparum genome Figure 2
Distribution of piggyBac insertion sites in the P. falciparum genome. (a) A representation of the 14 P. falciparum chro-
mosomes with piggyBac insertion loci (represented by red vertical lines) shows extensive distribution of piggyBac insertions 
through out the parasite genome. (b) Comparison of chromosomal distribution of piggyBac insertions to the percent genome 
content of each chromosome shows unbiased insertions into P. falciparum genome. Plot and curve fits of percent piggyBac 
insertions and percent chromosome size are depicted in the inset.BMC Microbiology 2009, 9:83 http://www.biomedcentral.com/1471-2180/9/83
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piggyBac insertions in the genome are random but preferentially occur in 5' untranslated regions Figure 3
piggyBac insertions in the genome are random but preferentially occur in 5' untranslated regions. (a) Genomic 
transcription units were defined to include 2 kb of 5' UTR, the coding sequence, the introns and 0.5 kb of 3' UTR, based on 
previous studies in Plasmodium [48,49]. (b) Comparison of gene functions of all annotated genes in the genome (outer circle) to 
genes in piggyBac-inserted loci (inner circle) shows an equivalent distribution confirming random insertions in the parasite 
genome. (c) Comparison of stage-specific expression of all annotated genes (outer circle) to those in piggyBac-inserted loci 
(inner circle) validates the ability of piggyBac to insert in genes expressed in all parasite life cycle stages. (d) A comparison of pig-
gyBac-inserted TTAA sequences to TTAA sequences randomly selected from the genome showed preferential insertion of pig-
gyBac into 5' UTRs of genes (asterisk- χ2 test, df 1, P = 1.5 × 10-12) whereas a significantly lower number of insertions were 
observed in CDS and introns (double asterisks- χ2 test, df 1, P = 1.09 × 10-13).BMC Microbiology 2009, 9:83 http://www.biomedcentral.com/1471-2180/9/83
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Validation of a phenotypic screen in P. falciparum
The preferential insertion of piggyBac into transcription
units prompted us to investigate the feasibility of forward
genetic studies in P. falciparum that have been completely
lacking thus far. Little is known about what metabolic
pathways and processes are essential for parasite growth
and survival in the blood of the vertebrate host, and there-
fore we screened the erythrocytic stages of P. falciparum
mutant clones for attenuated growth phenotypes. We first
screened for mutant clones that appeared to have aberrant
growth rate by standard light microscopy methods and
then studied them further by performing more precise
growth assays. The mutant clones selected for growth
analysis contained single piggyBac  insertions in their
genomes in either coding sequences or 5' UTRs and were
associated with several metabolic pathways (Fig. 5a). To
confirm that piggyBac  insertion into the genome alone
does not affect growth, additional mutant clones were
included as controls. An exponential growth curve was
generated for each mutant clone by estimating para-
sitemias every 24 hrs for 7 days using flow cytometry as
described before [25,26] with some modifications. Four
mutant clones (A5, B7, E6 and F3) displayed significantly
reduced growth rate as compared to five other insertional
mutants (B3, B4, F10, G1, and H11) and the wild type
(WT) clones (Fig. 5b). The experiment was performed
three times, with two sub-clones for each mutant and sim-
ilar results were obtained in all experiments (data not
shown). The parasite exponential growth curve was fur-
ther used to estimate the individual doubling times of the
mutant clones as described previously [26] that confirmed
the observed attenuated phenotypes (Table 1, See Fig. S1
in Additional file 2). Knock out of gene expression was
confirmed in clones with insertions in coding sequences
by RT-PCR (See Fig. S2 in Additional file 3). Clones A5
and F3 with insertions in the coding sequences of
PFF0770c and MAL8p1.104, respectively, were the most
affected with an approximate growth rate of only 30% as
piggyBac inserts into AT-rich regions of the P. falciparum genome Figure 4
piggyBac inserts into AT-rich regions of the P. falciparum genome. (a) Nucleotide composition analysis of the flanking 
sequences showed that piggyBac inserted TTAA sites preferentially occur in the middle of an AT-rich core of 10 nucleotides 
predominantly with 'T's upstream (χ2 test, df 1, P = 6.3 × 10-5) and 'A's downstream (χ2 test, df 1, P = 2.07 × 10-8) as compared 
to randomly selected genomic TTAA sequences. (b) A comparison of nucleotide composition of flanking sequences only in the 
5' untranslated regions (UTRs) of piggyBac inserted and randomly selected TTAA sequences further confirms the specificity of 
piggyBac for AT-rich target sites.BMC Microbiology 2009, 9:83 http://www.biomedcentral.com/1471-2180/9/83
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Table 1: Doubling time estimation of P. falciparum mutant clones
Clone ID Doubling time estimate (hours) Standard error 95% CI P value t value df
A5 22.07 0.26 21.53 22.60 0.00007 7.4656 7
B3 17.89 0.06 17.77 18.00 0.97376 -2.3316 7
B4 18.45 0.10 18.25 18.66 0.41380 0.2261 7
B7 19.70 0.17 19.34 20.06 0.00368 3.7297 7
E6 19.28 0.12 19.04 19.52 0.00565 3.4086 7
F3 21.98 0.17 21.64 22.33 0.00001 10.5459 7
F10 17.83 0.09 17.64 18.03 0.97735 -2.4318 7
G1 18.17 0.08 18.02 18.33 0.83353 -1.0400 7
H11 18.03 0.11 17.80 18.26 0.89928 -1.4098 7
WT 18.39 0.06 18.26 18.52 N/A: WT is reference
Doubling times for mutant parasite clones were estimated using their respective best-fit growth curves (See Fig. S1 in Additional file 2). Simple two-
tailed t-test was then used to test the significance of differences in doubling time of mutant clones with wild type (WT) P. falciparum clones (average 
of three NF54 clones) as the reference. Significant P values, based on alpha = 0.05, are highlighted in bold.
A phenotype screen for attenuated blood-stage growth Figure 5
A phenotype screen for attenuated blood-stage growth. (a) A schematic of mutant P. falciparum clones selected for 
growth rate analysis. Black vertical and horizontal arrows indicate the insertion site and orientation of the piggyBac transposon, 
respectively. The gene schematic, description and expression stages were all obtained from the PlasmoDB database at http://
www.plasmodb.org. (b) Growth curves of 9 insertional mutant clones, were obtained by plotting parasite fold change against 
time. For the wild type (WT), an average of fold changes from three different NF54 clones was used. The order of samples, 
from top to bottom, indicates a decrease in parasite fold changes. (c) A bar-graph of fold changes in parasite numbers after 7 
days of growth revealed a spectrum of attenuated growth phenotypes in several mutant clones when compared to the wild 
type clones. The error bars in (b) and (c) represent standard deviation from the mean of 3 measurements.BMC Microbiology 2009, 9:83 http://www.biomedcentral.com/1471-2180/9/83
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compared to the WT clones (Fig. 5c). The attenuated
growth rates observed in these mutant clones substantiate
their significance in intra-erythrocytic development of the
parasite, though additional studies are required to charac-
terize the attenuation mechanisms.
Discussion
Persistent problems with drug resistance and the critical
need to identify novel targets for therapeutic intervention
creates a continuing need to improve our understanding
of what is important for growth and development of
malaria parasites. A major barrier in experimental malaria
research has been a limited ability to manipulate P. falci-
parum genes to determine their functions and associated
pathways of interactions within the parasite. Large-scale
mutagenesis screens are vital for improving our under-
standing of Plasmodium biology and functional analysis of
its genome. Random transposon mutagenesis is a power-
ful approach to identify critical biological processes in an
organism and is an approach successfully applied in
numerous eukaryotes [11-13]. In particular, piggyBac has
become widely used to manipulate genomes and is cur-
rently the preferred vector of choice for gene discovery and
validation of gene function in Drosophila and the labora-
tory mouse [17,20,27-30]. We therefore evaluated piggy-
Bac as a novel genetic tool for the functional analysis of
the P. falciparum genome.
Several transposon and transposase plasmids were created
and tested in P. falciparum for maximum transformation
efficiency. All the plasmids tested transformed with similar
efficiencies except for the helper plasmid, pDCTH, with the
double promoter that almost doubled the transformation
efficiency. There were no apparent differences in integra-
tion specificities of the various plasmids as insertions in the
genome were randomly distributed in all cases. The pres-
ence of different selectable markers, hDHFR and BSD, in
plasmids pLBacII-HDH and pLBacII-HBH respectively,
allows re-transformation and complementation of previ-
ously transformed drug-resistant P. falciparum clones. The
plasmids pLBacII-HDH-GFP and pLBacII-HDH-eGFP can
trap promoters in the genome if inserted in the right orien-
tation downstream to an endogenous promoter as shown
previously [31]. These plasmids can also be modified for
stable transgene expression with or without GFP tag. Para-
sites transformed with pLBacII-HDGH, with hDHFR-GFP
fusion as selectable marker, display high levels of fluores-
cence and are amenable to sorting by Fluorescence acti-
vated cell sorter (FACS). Transformation with the plasmid
pLBacII-HDH-KanOri inserts the kanamycin resistance
gene and a pUC origin of replication into the parasite
genome that allows for plasmid rescue from the genome
for easy identification of insertion sites.
The genome-wide integration of piggyBac into genes in all
functional categories, expressed in all parasite life cycle
stages, validates its application in whole-genome muta-
genesis of P. falciparum. Almost all mutant P. falciparum
clones generated had single piggyBac insertions in their
genomes, which will aid in easy correlation of mutant
phenotypes to their respective genotypes. The increased
number of insertions obtained in 5' UTRs of genes indi-
cates either active changes in chromatin structure allow
easy access for piggyBac to the genomic DNA or the affinity
of the transposase for chromatin associated factors unique
to these regions. Alternatively, this skewed distribution
could simply be the inability to recover mutants with
insertions in coding sequences of essential genes, whereas
insertions in 5' UTRs of essential genes may not com-
pletely abolish gene expression and hence may not be
lethal.
From whole-genome mutagenesis perspectives, insertions
in 5' UTRs may have a varied effect on neighbouring gene
expression. Insertions in 5' UTRs could either increase
gene expression, possibly due to better recruitment of
transcription machinery, or decrease gene expression by
blocking transcription. A meaningful approach would
therefore be to subject all 5' UTR mutants to phenotypic
analyses as either increased or decreased gene expression
can significantly alter intracellular activities. Such a sce-
nario might be particularly beneficial in identifying essen-
tial genes that cannot be knocked out in the parasite.
Nevertheless, 22% of the insertions were obtained in cod-
ing sequences generating 39 gene knockouts, which
almost equal the number of unique gene knockouts gen-
erated in P. falciparum thus far until a recent large-scale
study achieving 53 gene knockouts [32], using conven-
tional methods [10]. Such high propensity to create gene
disruptions and the ability to rapidly generate stable lines
of mutant clones, warrants the use of piggyBac in large-
scale mutagenesis studies not only to identify gene func-
tions, but also to discriminate the essential and dispensa-
ble regions of the parasite genome that will further
confine the search for potent drug targets.
The most significant application of random mutagenesis
is the ability to perform forward genetic screens to select
mutants of a desired phenotype. Our limited phenotypic
screen for attenuated parasite growth confirmed the feasi-
bility of such approaches in P. falciparum by identifying
several genes and pathways critical for blood-stage devel-
opment. One of the most severely affected mutant para-
sites identified in our screen is a knockout of MAL8P1.104
(clone F3), which is the Plasmodium orthologue of yeast
Caf1 (CCR4-associated factor 1) [33]. In yeast, CAF1 is a
component of CCR4-NOT complex that is a global regu-
lator of gene expression, controlling chromatin remodel-
ling, transcriptional regulation, mRNA stability and
protein degradation [34]. Experimental protein interac-
tion data indicates a similar functional complex exists in
P. falciparum [7] and with a scarcity of known transcrip-BMC Microbiology 2009, 9:83 http://www.biomedcentral.com/1471-2180/9/83
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tion factors or identifiable conserved regulatory elements
in Plasmodium, deadenylation may be extremely signifi-
cant in controlling gene expression through regulating
mRNA abundance by degradation [35].
The significance of protein phosphorylation and dephos-
phorylation in regulating parasite cellular activities is also
clearly demonstrated by the attenuated growth phenotype
of our knockout of PFF0770c (clone A5), which encodes
one of the 12 type 2C protein phosphatases (PP2C) found
in Plasmodium [36]. PP2Cs carry out a wide range of func-
tions in higher eukaryotes including intracellular signal-
ling and providing cell cycle and developmental check
points [37-39]. Two PP2Cs, in the closely related apicom-
plexan Toxoplasma, were recently shown to be involved in
parasite motility and host cell modulation [40,41].
Another mutant clone displaying attenuated growth was a
knockout of PF10_0350 (clone E6) that codes for a hypo-
thetical protein unique to Plasmodium species and attests
to the theory that such unique Plasmodium genes need to
be investigated further as antimalarial targets. piggyBac
insertion in the 5' UTRs of PFC0271c and PFC0275w,
coding for glutaredoxin and glycerol-3 phosphate dehy-
drogenase, respectively, resulted in increased levels of
both transcripts in the mutant clone B7 as seen by quanti-
tative RT-PCR (data not shown), indicating that optimal
expression of genes is essential for normal parasite
growth.
Several other phenotypic screens such as those for virulence,
drug resistance, gametocytogenesis and transmissibility of
infection to mosquito hosts can now be accomplished in P.
falciparum  that will contribute immensely to our current
understanding of parasite biology.
Apart from its application in whole-genome mutagenesis
and phenotype screens, piggyBac is also a powerful tool for
stable transgene expression in P. falciparum as any parasite
strain or clone of interest can be transformed. We have
confirmed the functionality of piggyBac system in three
different strains of P. falciparum thus far, including, NF54,
3D7, and HB3, and have obtained genomic insertions of
up to 7 kb of DNA (including the drug selection cassette)
with no reduction in transformation efficiency (Balu and
Adams, unpublished data) [42]. The ability to express
transgenes stably from the genome offers numerous pos-
sibilities to study various biological aspects of the parasite
such as, coordinated gene expression, phenotypic effects
of copy number variations and protein trafficking.
Conclusion
Despite years of efforts, Plasmodium biology remains puz-
zling due to its complexity and refractoriness to routine
genetic analyses. By using the piggyBac transposable ele-
ment in P. falciparum, we have clearly demonstrated the
possibility of whole-genome mutagenesis and forward
functional genomics in this lethal malaria parasite that
will drastically advance our understanding of Plasmo-
dium's parasitic and pathogenic abilities and quicken the
search for new drug targets and vaccine candidates.
Methods
Plasmid constructs
piggyBac  plasmids used for transfections were derived
from previously reported plasmids pXL-BACII-DHFR and
pHTH [21].
pLBacII-HDH-pXL-BacII-DHFR was digested with XhoI
and the site was removed by filling in the overhangs with
klenow and religation to yield pLBacII-DHFR. The human
DHFR selection cassette in pLBacII-DHFR was then
replaced with a different human DHFR drug selection cas-
sette from the plasmid pHD22Y [43] using EcoRI/BamHI
to yield pLBacII-HDH.
pLBacII-HDH-GFP- The gfp coding sequence along with 3'
Pbdhfr was amplified as a single fragment from the vector
pHH2 [44] by PCR with extensions for restriction sites
SpeI and ApaI using primers F-ACTAGTGCG-
GCCGCCTACCCT and R-GGGCCCGGTACCCTCGA-
GATCTTAGAATGAAGATCTTATTAC. The PCR product
was then cloned into pGEM-Teasy vector (Promega) and
sub-cloned into pLBacII-HDH using ApaI and SpeI.
pLBacII-HDH-eGFP- A 200 bp region of 5' eba-175 was
amplified from the P. falciparum genome using primers F-
ATCGATGAATATAATTGATTGATTGTAATAAAAAGTG
and R-GGGCCCTGTATGCACATTGAATATATTTATATGT-
TATTATC and cloned into pLBacII-HDH-GFP as a ClaI/
ApaI fragment.
pLBacII-HDH-KanOri- The kanamycin resistance gene
and pUC origin of replication were amplified as a single
fragment by PCR from the vector pEGFP-C1 (Clontech)
using primers F-ATGATGATGGGATCCAAATGTGCGCG-
GAACCCC and R-ATGATGATGGGATCCGCAAAAG-
GCCAGCAAAAGG and cloned into pGEM-Teasy vector
(Promega). The fragment was then sub-cloned into the
plasmid pLBacII-HDH as a BamHI fragment.
pLBacII-HBH- The hDHFR coding sequence was first cut
out from the vector pHD22Y using NsiI and HindIII and
replaced with the blasticidin-S-deaminase (BSD) coding
sequence that was cut out from the vector pCBM-BSD [45]
using NsiI and HindIII. The BSD selection cassette in
pHD22Y was then moved as an EcoRI/BamHI fragment
into the vector pL-BacII-DHFR to yield pLBacII-HBH.
pLBacII-HDGH- The hDHFR-GFP fusion gene was cut out
from the vector pHDGFP2 [46] using NsiI and HindIII
and cloned into pHD22Y replacing the human DHFRBMC Microbiology 2009, 9:83 http://www.biomedcentral.com/1471-2180/9/83
Page 10 of 12
(page number not for citation purposes)
coding sequence. The whole selection cassette was then
moved as an EcoRI/BamHI fragment into the vector
pLBacII-DHFR to yield pLBacII-HDGH.
pDCTH- The plasmid with a dual promoter for trans-
posase expression was created by PCR amplifying 5' Pcd-
hfr-ts and 5' calmodulin as an EcoRI fragment from the
plasmid pHC1-CAT [22] using primers F-ATGATGGAAT-
TCCCTGATATATTTCTATTAGGTATTTATTA; R-ATGAT-
GGAATTCTTTGTAAGTTTTAGGTGTGTGTAT and
swapping it with the 5' hsp86 region in the helper plasmid,
pHTH.
Parasite culture and transfection
P. falciparum clone NF54 was cultured in human erythro-
cytes at 5% hematocrit in RPMI1640 medium containing
0.5% Albumax II, 0.25% sodium bicarbonate and 0.01
mg/ml gentamicin. Transfections were performed using
red blood cells as described previously [21]. Briefly,
mature blood-stage parasites were purified on a MACS
magnetic column (Miltenyi Biotec) and 1 million purified
parasites were added to erythrocytes loaded with 100 μg
of the transposon plasmid and 50 μg of the transposase
plasmid to start a 5 ml parasite culture. Individual mutant
clones were obtained by limiting dilution of parasites
post-drug selection.
Identification of piggyBac insertion sites
Genomic DNA (2 μg) extracted from transformed para-
sites was digested with 10 units of either Dra I or Rsa I and
used either in inverse PCR [21] or vectorette PCR reactions
according to manufacturer's instructions (UVS1 Vec-
torette™ Genomic Systems, Sigma). The amplified PCR
products were sequenced with primers in piggyBac
inverted terminal repeats [21] and analyzed using
MACVECTOR software (MacVector, Inc.). Insertion sites
were identified by performing BLAST searches using NCBI
http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/
BlastGen.cgi?taxid=5833 and PlasmoDB databases [23].
Parasite growth assays, flowcytometry and estimation of 
doubling times
Growth assays were performed by maintaining asynchro-
nous cultures of P. falciparum wild type and mutant clones
at parasitemias 0.5–2% in 96-well plates by diluting every
48 hrs. Parasite cultures were plated in triplicates for each
time point and samples were taken every 24 hrs for 7 days
and fixed in 0.05% glutaraldehyde after removal of cul-
ture medium. Flow cytometry was used to estimate para-
sitemia as described before [25,47] by staining parasites
with Ethidium bromide and analyzing using FACSCanto™
II flowcytometry system (Becton, Dickinson and Com-
pany) in a high throughput format. A total of 20,000 cells
were counted for each sample. The data were analyzed
using FACSDIVA™ software (Becton, Dickinson and Com-
pany). Growth rate (defined as the change in parasite
numbers every 24 hrs over a period of 7 days) analyses
were performed using SAS (9.1). The total number of par-
asites (y) (parasitemia × dilution factor), was plotted
against time (×) and fitted to the exponential growth
curve
where, D is the intrinsic parasite doubling time and m0 is
the theoretical parasite number at time 0. To compare
directly the growth rate of parasite clones with slightly dif-
ferent starting parasitemias, the -fold increase of the para-
site number, normalized to have a single theoretical
parasite for each culture at time 0, was used for graphing
the growth curve [26]. One hundred parameter initiation
values ranging from 5 to 105 were tested and the best con-
verging model with the smallest Sum Square of Error
(SSE) was chosen for estimation of doubling time.
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